Investigation of the mechanism of glucocorticoid action on dopamine agonist sensitivity.
Crocker
A D
AD
Department of Clinical Pharmacology, Centre for Neuroscience, Adelaide, Australia.
Stanley
J E
JE
Cameron
D L
DL
D000302:Adrenal Cortex / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000315:Adrenalectomy; D000450:Aldosterone / Q000494:pharmacology; D000732:Androstanols / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003342:Corpus Striatum / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology*; D005938:Glucocorticoids / Q000494:pharmacology*; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects; D014018:Tissue Distribution
D000305:Adrenal Cortex Hormones; D000732:Androstanols; D018491:Dopamine Agonists; D005938:Glucocorticoids; D011956:Receptors, Cell Surface; D011954:Receptors, Dopamine; D000450:Aldosterone; C049154:11,17-dihydroxy-6-methyl-17-(1-propynyl)androsta-1,4,6-triene-3-one